tiprankstipranks
Towa Pharmaceutical Co Ltd (JP:4553)
:4553
Japanese Market

Towa Pharmaceutical Co (4553) Income Statement

Compare
0 Followers

Towa Pharmaceutical Co Income Statement

Last quarter (Q1 2024), Towa Pharmaceutical Co's total revenue was ¥62.57B, an increase of 14.70% from the same quarter last year. In Q1, Towa Pharmaceutical Co's net income was ¥5.50B. See Towa Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
¥ 227.93B¥ 208.86B¥ 165.62B¥ 154.90B¥ 110.38B
Gross Profit
¥ 81.38B¥ 72.71B¥ 70.19B¥ 65.45B¥ 50.65B
Operating Expenses
¥ 63.74B¥ 67.20B¥ 50.98B¥ 45.53B¥ 34.50B
Depreciation and Amortization
¥ 17.89B¥ 19.41B¥ 10.95B¥ 10.43B¥ 8.29B
EBITDA
¥ 35.54B¥ 24.92B¥ 29.49B¥ 30.35B¥ 24.46B
Operating Income
¥ 17.65B¥ 5.51B¥ 19.20B¥ 19.92B¥ 16.14B
Other Income/Expenses
¥ 6.81B¥ -909.00M¥ 3.04B¥ -1.20B¥ 4.57B
Pretax Income
¥ 24.46B¥ 4.61B¥ 22.25B¥ 18.73B¥ 20.71B
Net Income
¥ 16.17B¥ 2.20B¥ 15.91B¥ 13.96B¥ 14.50B
Per Share Metrics
¥ ―¥ ―¥ ―¥ ―¥ ―
Basic EPS
¥ 328.58¥ 44.72¥ 323.35¥ 283.62¥ 294.72
Diluted EPS
¥ 328.58¥ 43.72¥ 316.19¥ 271.93¥ 272.61
Weighted Average Shares Outstanding
49.22M 49.22M 49.22M 49.21M 49.21M
Weighted Average Shares Outstanding (Diluted)
49.22M 50.34M 50.32M 51.28M 53.17M
Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis